Time For Independent FDA? COVID-19 Political Pressure Reignites Debate
Executive Summary
The political spotlight on the Food & Drug Administration during the COVID-19 pandemic has renewed the long-standing debate as to whether FDA should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.
You may also be interested in...
Pandemic Perspectives: How COVID Emergency Use Authorizations Could Reshape US FDA
From re-examining the FDA’s place in the broader US government to how fast and flexible it can be clearing therapies in non-emergency times, the COVID-19 EUA experience is expected to have a long-lasting impact on the agency.
US FDA Independence May Be In The Eye Of The Beholder
Former commissioners continue push to move FDA out of HHS, but the alternative could create a different kind of political influence rather than eliminate it.
Transparency, And A Mirror: US FDA Advice On COVID-19 Vaccine EUAs Finally Published – Twice
Everyone but Donald Trump seems happy that the guidance is finally here, with release appearing to be driven by FDA's disclosure of advisory committee materials.